The nine-year-old company, which once employed 200 people but now has less than 60, is the third in a triumvirate of kidney drug ventures started by a team led by Gerrit Klaerner.
The nine-year-old company, which once employed 200 people but now has less than 60, is the third in a triumvirate of kidney drug ventures started by a team led by Gerrit Klaerner.
